Shopping Cart

Cyprotex Plc (CRX)-Medical Equipment-Deals and Alliances Profile

SKU
GDME81970D
READ MORE
USD 250
Single User License
USD 250
Site License
USD 500
Corporate User License
USD 750

Cyprotex Plc (Cyprotex) provider of ADME-Tox contract research services. It provides these services to the Biotechnology, pharmaceutical, cosmetics/personal care, and chemical industries. The company's core capabilities include high quality mech

READ MORE
  • Details
  • Table Of Content
  • Licence Rights
  • Section Purchase
  • Products and Companies

Cyprotex Plc (Cyprotex) provider of ADME-Tox contract research services. It provides these services to the Biotechnology, pharmaceutical, cosmetics/personal care, and chemical industries. The company's core capabilities include high quality mechanistic toxicology, in vitro ADME screening services, and high content toxicology screening services, including proprietary CellCiphr toxicity prediction technology, predictive modelling using QSAR and PBPK techniques, including Cloe PK for in vivo PK prediction, and a range of endocrine and skin, ocular disruption services. Cyprotex partners with various organizations within the cosmetics and personal care industry, biotech and pharmaceutical industry, and the chemical industry. The company's operations are primarily carried out in the UK and the US. Cyprotex is headquartered in Cheshire, UK.

Cyprotex Plc (CRX)-Medical Equipment-Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

Financial Deals-Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.

Deals by Year-Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.

Deals by Type-Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.

Deals by Region-Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.

Deals by Sub-sector-Chart and table showing information on the number of deals and value reported by the company, by sub-sector.

Major Deals-Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's (major public companies) key financial metrics and ratios.

Business Description-A brief description of the company's operations.

Key Employees-A list of the key executives of the company.

Important Locations and Subsidiaries-A list and contact details of key centers of operation and subsidiaries of the company.

Key Competitors-A list of the key competitors of the company.

Key Recent Developments-A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements

The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy

The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company

Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.

Equip yourself with detailed information about the company's operations to identify potential customers and suppliers.

The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company

Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research

Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

READ MORE

Scope

Table of Contents

Table of Contents 2

List of Tables 3

List of Figures 4

Cyprotex Plc, Medical Equipment, Deals By Year, 2011 to YTD 2017 5

Cyprotex Plc, Medical Equipment Deals By Type, 2011 to YTD 2017 6

Cyprotex Plc, Medical Equipment, Deals By Region, 2011 to YTD 2017 7

Cyprotex Plc, Medical Equipment, Deals By Market, 2011 to YTD 2017 8

Cyprotex Plc, Medical Equipment, Deals Summary, 2011 to YTD 2017 9

Cyprotex Plc, Medical Equipment, Deal Details 10

Partnerships 10

Cyprotex Enters Into Agreement With InSphero For New 3D Microtissue Service 10

Cyprotex Enters Into Licensing Agreement With Sigma For Zinc Finger Nuclease Technology 11

Acquisition 11

Evotec Acquires Cyprotex for USD68 Million 11

Apredica Acquires CeeTox, In-Vitro Toxicological Assays And Screening Data Provider, For Up To US$6 Million 13

Cyprotex Plc-Key Competitors 15

Key Employees 16

Locations And Subsidiaries 17

Head Office 17

Other Locations & Subsidiaries 17

Recent Developments 18

Financial Announcements 18

Aug 02, 2016: Cyprotex: Interim Results 2016 18

Apr 01, 2016: Cyprotex Announces Final results for the year ended 31 December 2015 21

Corporate Communications 22

Sep 26, 2016: Cyprotex: Cyprotex appoint new Director of US Operations 22

Sep 26, 2016: Cyprotex appoint new Director of US Operations 23

Other Significant Developments 24

Jun 09, 2016: Cyprotex Purchase New IntelliCyt iQue Screener for Expansion of Cell-Based Services 24

Apr 26, 2016: Launch of GLP-Compliant Genotoxicity Services 25

Appendix 26

Methodology 26

About GlobalData 26

Contact Us 26

Disclaimer 26


List Of Figure

List of Figures

Cyprotex Plc, Medical Equipment, Deals by Type, 2011 to YTD 2017 1

Cyprotex Plc, Medical Equipment, Deals By Year, 2011 to YTD 2017 1

Cyprotex Plc, Medical Equipment, Deals By Region, 2011 to YTD 2017 1

Cyprotex Plc, Medical Equipment, Deals By Market, 2011 to YTD 2017 1

Cyprotex Plc, Medical Equipment, Deals By Year, 2011 to YTD 2017 5

Cyprotex Plc, Medical Equipment, Deals by Type, 2011 to YTD 2017 6

Cyprotex Plc, Medical Equipment, Deals By Region, 2011 to YTD 2017 7

Cyprotex Plc, Medical Equipment, Deals by Market, 2011 to YTD 2017 8


List Of Table

List of Tables

Cyprotex Plc, Medical Equipment, Key Facts, 2015 1

Cyprotex Plc, Medical Equipment, Deals Summary, 2011 to YTD 2017 1

Cyprotex Plc, Medical Equipment, Deals By Year, 2011 to YTD 2017 5

Cyprotex Plc, Medical Equipment Deals By Type, 2011 to YTD 2017 6

Cyprotex Plc, Medical Equipment, Deals By Region, 2011 to YTD 2017 7

Cyprotex Plc, Deals By Market, 2011 to YTD 2017 8

Cyprotex Plc, Medical Equipment, Deals Summary, 2011 to YTD 2017 9

Cyprotex Enters Into Agreement With InSphero For New 3D Microtissue Service 10

Cyprotex Enters Into Licensing Agreement With Sigma For Zinc Finger Nuclease Technology 11

Evotec Acquires Cyprotex for USD68 Million 11

Apredica Acquires CeeTox, In-Vitro Toxicological Assays And Screening Data Provider, For Up To US$6 Million 13

Cyprotex Plc, Key Competitors 15

Cyprotex Plc, Key Employees 16

Cyprotex Plc, Subsidiaries 17

To know more information on Purchase by Section, please send a mail to

Brand Description
History Color sit amet, consectetur adipiscing elit. In gravida pellentesque ligula, vel eleifend turpis blandit vel. Nam quis lorem ut mi mattis ullamcorper ac quis dui. Vestibulum et scelerisque ante, eu sodales mi. Nunc tincidunt tempus varius. Integer ante dolor, suscipit non faucibus a, scelerisque vitae sapien.